Reported Dec 27, 2017 · Terminated

Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, Rx Only, (2 mg/mL), 100 mL Flexible Bag,…

Claris Lifesciences Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Claris Lifesciences Inc · 1445 US Highway 130 · North Brunswick, NJ · 08902-3100

Is this the product you have?

    • Ciprofloxacin in Dextrose (5%) Injection
    • USP 200 mg in 100 mL 5% Dextrose
    • Rx Only
    • (2 mg/mL)
    • 100 mL Flexible Bag
  • Manufactured forClaris LifeScience Inc. North Brunswick NJ 08902 by Claris Injectables Ltd. Gujarat, India UPC 336000008242 NDC 36000-008-249
Lot codes and dates
    • A060192 01/2018
    • A060305 02/2018
    • A061038 08/2018
    • A0A0068 12/2018
    • A0A0404 04/2019

Where it was sold

  • Nationwide

Why it was recalled

Superpotent

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Claris Lifesciences Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Apr 20, 2020 · Data as of Sep 19, 7:13 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.